Institution statistics

INSTITUT CURIE - France 

Ranking results:

2012
Criterium:Position:
Overall Score:200-300
Total Project Funding:900-1000
Total Project Funding per Partner:200-300
Total Number of Projects:65
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:14
Diversity Index:41
2011
Criterium:Position:
Overall Score:500-600
Total Project Funding:100-200
Total Project Funding per Partner:200-300
Total Number of Projects:100-200
Networking Rank (Reputation):300-400
Partner Constancy:200-300
Project Leadership Index:600-700
Diversity Index:200-300
2010
Criterium:Position:
Overall Score:700-800
Total Project Funding:100-200
Total Project Funding per Partner:71
Total Number of Projects:200-300
Networking Rank (Reputation):800-900
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:700-800
2009
Criterium:Position:
Overall Score:100-200
Total Project Funding:700-800
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:1
Diversity Index:500-600
2008
Criterium:Position:
Overall Score:900-1000
Total Project Funding:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):500-600
Partner Constancy:600-700
Project Leadership Index:700-800
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:900-1000
Total Project Funding:400-500
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):700-800
Partner Constancy:400-500
Project Leadership Index:500-600
Diversity Index:> 1000

European project participation (2000-01-01 - 2013-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Total funding / No of participants

Projects:
Leadership:

Total number of projects: 114
As coordinator: 2
As participant: 61
Sole participant: 51
Coordinator / Participant Ratio: 0.03*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2000 502.900 10.989.862 2.040.203 4 7
2001 628.100 2.845.086 1.111.281 5 3
2002 338.700 8.105.241 1.378.343 3 7
2003 0 2.486.874 355.268 2
2004 0 27.426.514 1.985.408 6
2005 1.544.936 8.859.000 2.053.436 1 3
2006 1.713.756 29.078.016 3.484.533 2 5
2007 299.341 11.319.432 1.572.810 2 4
2008 2.746.762 29.057.713 4.359.296 5 5
2009 8.443.677 4.609.511 5.558.253 8 1
2010 7.000.483 75.558.400 13.070.080 4 8
2011 871.496 61.185.734 4.997.967 7 9
2012 9.300.385 2.997.000 4.103.864 5 1
2013 7.246.835 0 7.246.835 7
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE14
KAROLINSKA INSTITUTE10
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM9
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE9
WEIZMANN INSTITUTE OF SCIENCE9
EUROPEAN MOLECULAR BIOLOGY LABORATORY8
INSTITUT GUSTAVE ROUSSY8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD8
MEDICAL RESEARCH COUNCIL7
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS6
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE6
LEIDEN UNIVERSITY MEDICAL CENTER6
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV6
UNIVERSITY COLLEGE LONDON6
CANCER RESEARCH UK5
DANISH CANCER SOCIETY5
DEUTSCHES KREBSFORSCHUNGSZENTRUM5
ERASMUS UNIVERSITEIT ROTTERDAM5
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III5
LEIDEN UNIVERSITY5
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E V5
THE NETHERLANDS CANCER INSTITUTE / ANTONI VAN LEEUWENHOEK HOSPITAL5
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA5
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
COMMISSARIAT A L'ENERGIE ATOMIQUE4
DIAGNOSWISS4
INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL4
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER4
ISTITUTO EUROPEO DI ONCOLOGIA4
RUPRECHT KARLS UNIVERSITAET HEIDELBERG4
UNIVERSITAETSKLINIKUM ESSEN4
UNIVERSITEIT GENT4
UNIVERSITY OF SUSSEX4
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE3
DANMARKS TEKNISKE UNIVERSITET3
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH3
FLUIGENT3
FONDAZIONE TELETHON3
FORSCHUNGSZENTRUM KARLSRUHE3
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS3
GSFRESEARCH CENTER FOR ENVIRONMENT AND HEALTH3
INSTITUT PASTEUR3
INSTITUTE OF MACROMOLECULAR CHEMISTRY ACADEMY OF SCIENCES OF THE CZECH REPUBLIC3
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI3
KATHOLIEKE UNIVERSITEIT LEUVEN3
KING'S COLLEGE LONDON3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
NOVARTIS FORSCHUNGSSTIFTUNG ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH3
RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY3
THE HEBREW UNIVERSITY OF JERUSALEM3
THE UNIVERSITY OF EDINBURGH3
UNIVERSITAT DE BARCELONA3
UNIVERSITE CLAUDE BERNARD LYON 13
UNIVERSITEIT UTRECHT3
UNIVERSITY OF COPENHAGEN3
UNIVERSITY OF ZURICH3
UNIVERZITA PARDUBICE3
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ACADEMISCH ZIEKENHUIS GRONINGEN2
ALMA CONSULTING GROUP SAS2
ARTTIC2
ASSOCIATION POUR LA RECHERCHE ET LE DEVELOPPEMENT DES METHODES ET PROCESSUS INDUSTRIELS2
BEN GURION UNIVERSITY OF THE NEGEV2
BUNDESAMT FUER STRAHLENSCHUTZ2
CEINGE BIOTECNOLOGIE AVANZATE SCARL2
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN2
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL2
CONSORZIO MARIO NEGRI SUD2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
FEDERATION OF EUROPEAN CANCER SOCIETIES2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO2
FRIEDRICH ALEXANDER UNIVERSITAET ERLANGEN NUERNBERG2
FUNDACIO CENTRE DE RECERCA EN EPIDEMIOLOGIA AMBIENTAL CREAL2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSTITUT DE RADIOPROTECTION ET DE SURETE NUCLEAIRE2
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE2
IPSOGEN SAS2
ISTITUTO SUPERIORE DI SANITA2
JOHANNES GUTENBERG UNIVERSITAET MAINZ2
JOHANNES GUTENBERGUNIVERSITaeT MAINZ2
JOZEF STEFAN INSTITUTE2
KUNGLIGA TEKNISKA HOEGSKOLAN2
MAXPLANCKGESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
OSLO UNIVERSITETSSYKEHUS HF2
SATEILYTURVAKESKUS RADIATION AND NUCLEAR SAFETY AUTHORITY2
ST ANNA KINDERKREBSFORSCHUNG2
STICHTING KATHOLIEKE UNIVERSITEIT MORE PARTICULARLY RADBOUD UNIVERSITY NIJMEGEN MEDICAL CENTRE2
STUDIECENTRUM VOOR KERNENERGIE CENTRE D'ETUDE DE L'ENERGIE NUCLEAIRE2
SYDDANSK UNIVERSITET2
TECHNICAL RESEARCH CENTRE OF FINLAND2
TECHNISCHE UNIVERSITEIT DELFT2
TEL AVIV UNIVERSITY2
THE BABRAHAM INSTITUTE2
UNIVERSITA DEGLI STUDI DI PADOVA2
UNIVERSITAET ULM2
UNIVERSITAETSKLINIKUM ULM2
Constancy:

Total number of partners:693

Partner loyalty:
Frequent Partner: (> 2 projects): 272
Rare Partner: 421

Frequent / Rare Partner Ratio: 0.65

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES56
RTD HORIZONTAL TOPICS42
INDUSTRY AND TECHNOLOGY11
SOCIAL AND ECONOMIC CONCERNS6
ENERGY5

Project overview:

Start dateProjectacronymrolefundingpartners
2013-11-01MKlp2 - a mitotic kinesin and a prime target for cancer therapy MKLP2-MITOSIScoordinator261.3841
2013-03-01Mechanical activation of beta-catenin signalling BCATENIN_MECHANICScoordinator194.0461
2013-03-01The role of the influenza virus matrix protein M1 in budding adn virus release FLUMABUDcoordinator202.4051
2013-01-01Proliferation and Migration under External Constraints PROMICOcoordinator1.489.4001
2013-01-01Innate sensing of HIV and immune responses HIVINNATEcoordinator1.680.0001
2013-01-01Cell migration in gut homeostasis and cancer invasion - role of microenvironment STARLINcoordinator1.499.6001
2013-01-01Anatomical and Functional Dissection of Neural Circuits in the Zebrafish Optic Tectum ZEBRATECTUMcoordinator1.920.0001
2012-10-01Rational molecular Assessments and Innovative Drug Selection RAIDScoordinator5.999.64216
2012-09-01Love wave fully integrated Lab-on-Chip platform for food pathogen detection LOVE-FOODparticipant2.997.0007
2012-03-01Large-scale integrative biology of human dendritic cells IT-DCcoordinator1.498.9961
2012-03-01A novel role for histone chaperones in the dynamics of non-conventional substrates, the CENP-T/-W, complex at the centromere. CENHFDCcoordinator201.9321
2012-02-01Regulation of Polycomb Complex (PRC2) during development and in diseases REPODDIDcoordinator1.499.8151
2012-01-01Atoh1/Math1 regulation and function during cerebellar normal development and medulloblastoma ATOH1MEDULLOcoordinator100.0001
2011-11-01HEMatopoietic cell IDentity : genetic and epigenetic regulation in normal and malignant hematopoiesis HEM_IDparticipant3.269.70212
2011-11-01Dissecting the role of BRCA2 in the DNA damage response and exploiting its parts for anticancer therapy. DISSECTING BRCA2coordinator100.0001
2011-10-01Spatio-temporal Control of Cell Division in Fission Yeast SPTPCDR2coordinator186.2481
2011-09-01Chromatin Dynamics In Genome Integrity CHRODIGIcoordinator100.0001
2011-04-01In vivo analysis of DISC1 function in synaptogenesis and axonal transport DISC1 & AXOGENESIScoordinator100.0001
2011-04-01Microbes in Allergy and Autoimmunity Related to the Skin MAARSparticipant5.978.54110
2011-03-01Regulation of chromatin compaction in response to DNA damage in mammalian cells CHROMATINDAMAGEcoordinator185.2481
2011-03-01The Polycomb Repression Complex 2 (PRC2): Mechanisms of recruitment and role in tumorigenesis PREMORRITcoordinator100.0001
2011-03-01The mechanism of retrograde trafficking by retromer. RETROMERcoordinator100.0001
2011-03-01TreatPolyQ ? Industrial Academic Initial Training Network towards treatment of Polyglutamine Diseases. TREATPOLYQparticipant3.757.31814
2011-02-01Epidemiological study to quantify risks for paediatric computerized tomography and to optimise doses. EPI-CTparticipant2.998.59418
2011-01-01EUROCANCER STEMCELL TRAINING NETWORK EUROCSCTRAININGparticipant3.252.4829
2011-01-01Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes RATHERparticipant5.995.7868
2011-01-01EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS ENCCAparticipant11.997.95833
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428
2011-01-01Systems biology of liver cancer: an integrative genomic-epigenomic approach MODHEPparticipant11.936.89913
2010-12-01Transport and signalling in Polarized Cells TRANSPOLparticipant3.835.98010
2010-11-01ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours ASSETparticipant11.999.15614
2010-11-01Tools for minimally invasive diagnostics DIATOOLSparticipant5.000.0007
2010-10-01Toward an HIV-1 vaccine: Molecular mechanisms regulating the cryptic innate immune response to HIV-1 HIV INNATE IMMUNITYcoordinator100.0001
2010-10-01Epigenetics towards systems biology EPIGENESYSparticipant11.995.02419
2010-09-01Nanosystems for the early Diagnosis of Neurodegenerative diseases NADINEparticipant9.000.00016
2010-06-01Systems Biology of Stem Cells and Reprogramming SYBOSSparticipant10.530.00010
2010-06-01Epigenetic challenges in centromere inheritance during the cell cycle ECCENTRICcoordinator2.490.4831
2010-06-01Systems Biology of Mitosis MITOSYSparticipant10.198.24113
2010-05-01Epigenetic regulation and monoallelic gene expression: the X-inactivation paradigm and beyond EPIGENETIXcoordinator2.860.0001
2010-01-01Investigating the link between centrosomes, stem cells and cancer CENTROSTEMCANCERcoordinator1.550.0001
2010-01-01Low Dose Research towards Multidisciplinary Integration DOREMIparticipant12.999.99912
2009-12-01Spatio-temporal regulation of antigen presentation and cell migration STRAPACEMIcoordinator1.980.0001
2009-11-01Nucleosome structure & function across biological scales and biological function NUCLEOSOME4Dparticipant4.609.51117
2009-11-01Lateral diffusion in artificial lipid nanotubes NANOTUBEcoordinator30.0001
2009-10-01Actin-membrane interaction in biomimetic and living cellular systems studied with a novel, high precision optical method BIOMIMETIC-CORTEXcoordinator171.0331
2009-10-01Chromatin dynamics during X-inactivation: assessing the role of different chromatin changes in the loss of gene activity and the gain of gene silencing SIMAOROCHAXCIcoordinator165.4441
2009-07-01Integrative phagosomal biology: Antigen presentation and developmental programs in dendritic cells PHAGODCcoordinator2.214.7021
2009-07-01Integrated micro-nano-opto fluidic systems for high-content diagnosis and studies of rare cancer cells CAMINEMScoordinator3.551.1439
2009-06-01Biophysical determinants of the adhesion strength of gap junctions GAPJUNCTION STRENGTHcoordinator168.2791
2009-04-01Identification of the molecular mechanisms whereby actin and myosin1b shape sorting endosomes ENDOMYOSHAPEcoordinator163.0761

overview shows latest 50 from 114 projects (2000-01-01 - 2013-12-31)

Alias institution names:
  • INSTITUT CURIE

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum